• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Positron Corp Secures $2M For Market Expansion & Growth

    GLOBENEWSWIRE

    Positron Announces Transition to Reporting SEC Company

    GLOBENEWSWIRE

    Positron Corp. Partners With MedAxiom In Industry Agreement

    GLOBENEWSWIRE

    Positron Move Headquarters, Strategically Redomiciles to Delaware

    GLOBENEWSWIRE

    Positron Corp. Expands Market with NeuSight PET-CT Scanner Sale

    GLOBENEWSWIRE

    Positron Engages Skyline For Investor & Financial Outreach

    GLOBENEWSWIRE

    Positron Corporation Announces Sale of NeuSight PET-CT Scanner

    GLOBENEWSWIRE

    Positron Introduces New Advanced PET-CT System

    GLOBENEWSWIRE

    Positron Announces Attrius® PET System Sale

    GLOBENEWSWIRE

    Positron Corporation Enters OEM Supply and Distribution Agreement

    GLOBENEWSWIRE

    Positron Corporation Enters Agreement to Acquire FDA 510(k) for NeuSight PET-CT

    GLOBENEWSWIRE

    Positron Corporation Announces Attrius® PET System Sale

    GLOBENEWSWIRE

    Positron Corporation Announces Attrius® PET System Sale

    GLOBENEWSWIRE

    Positron Corporation Announces Start of Clinical Study of Affinity PET-CT Device

    GLOBENEWSWIRE

    Positron Orders Six Attrius PET Systems and Components from Neusoft Positron

    GLOBENEWSWIRE

    Positron Enters New Manufacturing & Components Supplier Cooperative with Neusoft Subsidiary

    GLOBENEWSWIRE

    Positron Corporation Announces First Step in Validation of its New PET-CT Device

    GLOBENEWSWIRE

    Positron Corporation Announces Key Sales & Services Personnel Hire

    GLOBENEWSWIRE

    Positron Corp Retains FDA Consulting Firm in Preparation for 510K NDA

    GLOBENEWSWIRE

    Positron Issues Shareholder Letter to Discuss Key Highlights & 2022 Objectives

    GLOBENEWSWIRE

    Positron Announces Timeline for Becoming Current with its OTC Reporting

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.